Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?

Article indépendant

PROD'HOMME, Chloé | TOUZET, Licia | PIERRAT, Magali | CHEVALIER, Luc | LESAFFRE, Helene | BERTHON, Celine | COITEUX, Valerie | BARBIEUX, Sarah | BEAUVAIS, David | BAUSCHERT, Loïc | GOURSAUD, Laure | MANIER, Salomon | FACON, Thierry | CHARETTE, Marie de

Patients with hematological malignancies (HMs) have less access to palliative care (PC) than other patients with cancer and benefit from it later on in the course of their disease, although symptom burden is just as heavy. We created a specialized outpatient PC consultation in the hematology department to improve the quality of patient management and enhance cooperation with hematologists. We found that although patient characteristics and survival were extremely variable, they all had in common a need for symptom management and care coordination. As a result of the consultation, hematology teams called upon a specialized PC multidisciplinary team more often to meet patients hospitalized within their departments, and more patients with HMs were hospitalized in PC units. [Début de l'article]

http://dx.doi.org/10.1182/bloodadvances.2021004369

Voir la revue «Blood advances, 5»

Autres numéros de la revue «Blood advances»

Consulter en ligne

Suggestions

Du même auteur

Can palliative care consultation increase int...

Article | PROD'HOMME, Chloé | Blood advances | n°8 | vol.5

Patients with hematological malignancies (HMs) have less access to palliative care (PC) than other patients with cancer and benefit from it later on in the course of their disease, although symptom burden is just as heavy. We cre...

Can palliative care consultation increase int...

Article indépendant | PROD'HOMME, Chloé | Blood advances | n°8 | vol.5

Patients with hematological malignancies (HMs) have less access to palliative care (PC) than other patients with cancer and benefit from it later on in the course of their disease, although symptom burden is just as heavy. We cre...

Dexmedetomidine and clonidine in palliative m...

Article indépendant | PROD'HOMME, Chloé | BMJ supportive & palliative care | n°e3 | vol.13

OBJECTIVES: Alpha-2 agonists have analgesic and sedative properties that can prove interesting in palliative care. The main objective of this study was to describe the use of clonidine and dexmedetomidine in palliative care units ...

De la même série

Can palliative care consultation increase int...

Article indépendant | PROD'HOMME, Chloé | Blood advances | n°8 | vol.5

Patients with hematological malignancies (HMs) have less access to palliative care (PC) than other patients with cancer and benefit from it later on in the course of their disease, although symptom burden is just as heavy. We cre...

What do patients think about palliative care?...

Article indépendant | BARATA, Anna | Blood advances

Palliative care (PC) benefits patients undergoing hematopoietic stem cell transplantation (HSCT) but remains under-utilized. Whereas transplant physicians report concerns regarding how patients perceive PC, HSCT recipients' percep...

Chargement des enrichissements...